KOHJIN BIO CO LTD (177A.T)
JPY 1670.0
(3.73%)
JPY 1670.0
(3.73%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 6.58 Billion JPY | 7.41% |
| 2022 | 6.13 Billion JPY | 9.64% |
| 2021 | 5.59 Billion JPY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 FY | 6.58 Billion JPY | 7.41% |
| 2023 Q4 | 6.58 Billion JPY | 4.13% |
| 2023 Q3 | 6.32 Billion JPY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| PRISM BioLab Co.,LTD | 1.21 Billion JPY | -443.931% |
| GNI Group Ltd. | 62.39 Billion JPY | 89.439% |
| Linical Co., Ltd. | 18.53 Billion JPY | 64.459% |
| Trans Genic Inc. | 9.81 Billion JPY | 32.837% |
| MEDINET Co., Ltd. | 5.63 Billion JPY | -16.953% |
| Soiken Holdings Inc. | 6.94 Billion JPY | 5.137% |
| Cytori Cell Research Institute, Inc. | 5.81 Billion JPY | -13.29% |
| AnGes, Inc. | 28.89 Billion JPY | 77.194% |
| OncoTherapy Science, Inc. | 867.27 Million JPY | -659.773% |
| Nxera Pharma Co., Ltd. | 157.19 Billion JPY | 95.808% |
| Immuno-Biological Laboratories Co., Ltd. | 1.61 Billion JPY | -307.105% |
| NanoCarrier Co., Ltd. | 5.07 Billion JPY | -29.934% |
| Carna Biosciences, Inc. | 4.34 Billion JPY | -51.482% |
| CanBas Co., Ltd. | 2.43 Billion JPY | -170.847% |
| D. Western Therapeutics Institute, Inc. | 2.37 Billion JPY | -177.636% |
| RaQualia Pharma Inc. | 6.93 Billion JPY | 4.92% |
| Chiome Bioscience Inc. | 1.75 Billion JPY | -276.22% |
| Kidswell Bio Corporation | 5.08 Billion JPY | -29.57% |
| PeptiDream Inc. | 67.12 Billion JPY | 90.184% |
| Oncolys BioPharma Inc. | 2.04 Billion JPY | -222.911% |
| Ribomic Inc. | 3.54 Billion JPY | -85.758% |
| SanBio Company Limited | 5.04 Billion JPY | -30.552% |
| Healios K.K. | 15.15 Billion JPY | 56.52% |
| BrightPath Biotherapeutics Co., Ltd. | 1.23 Billion JPY | -435.605% |
| Kubota Pharmaceutical Holdings Co., Ltd. | 3.01 Billion JPY | -118.479% |
| Delta-Fly Pharma, Inc. | 1.47 Billion JPY | -346.99% |
| StemRIM | 9.08 Billion JPY | 27.43% |
| CellSource Co., Ltd. | 6.87 Billion JPY | 4.221% |
| FunPep Company Limited | 2.49 Billion JPY | -164.511% |
| Kringle Pharma, Inc. | 2.61 Billion JPY | -151.63% |
| Stella Pharma Corporation | 3.82 Billion JPY | -72.467% |
| TMS Co., Ltd. | 3.55 Billion JPY | -85.366% |
| Noile-Immune Biotech Inc. | 5.77 Billion JPY | -14.023% |
| Cuorips Inc. | 6.18 Billion JPY | -6.542% |
| K Pharma,Inc. | 3.31 Billion JPY | -98.839% |
| Takara Bio Inc. | 123.2 Billion JPY | 94.652% |
| ReproCELL Incorporated | 9.05 Billion JPY | 27.211% |
| PhoenixBio Co., Ltd. | 2.71 Billion JPY | -142.672% |
| StemCell Institute Inc. | 6.54 Billion JPY | -0.707% |
| Japan Tissue Engineering Co., Ltd. | 6.98 Billion JPY | 5.716% |
| CellSeed Inc. | 2.46 Billion JPY | -167.232% |